Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA PIRAMAL ENTERPRISES ASTRAZENECA PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 91.1 -27.0 - View Chart
P/BV x 16.5 0.6 2,985.5% View Chart
Dividend Yield % 0.3 4.0 7.4%  

Financials

 ASTRAZENECA PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
PIRAMAL ENTERPRISES
Mar-22
ASTRAZENECA PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs4,5803,013 152.0%   
Low Rs2,5291,612 156.9%   
Sales per share (Unadj.) Rs322.2586.3 55.0%  
Earnings per share (Unadj.) Rs24.656.4 43.7%  
Cash flow per share (Unadj.) Rs31.484.3 37.3%  
Dividends per share (Unadj.) Rs10.0033.00 30.3%  
Avg Dividend yield %0.31.4 19.7%  
Book value per share (Unadj.) Rs203.81,487.0 13.7%  
Shares outstanding (eoy) m25.00238.66 10.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.03.9 279.7%   
Avg P/E ratio x144.341.0 351.8%  
P/CF ratio (eoy) x113.127.4 412.3%  
Price / Book Value ratio x17.41.6 1,121.6%  
Dividend payout %40.658.5 69.4%   
Avg Mkt Cap Rs m88,863551,910 16.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,30221,350 10.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,056139,933 5.8%  
Other income Rs m1487,201 2.0%   
Total revenues Rs m8,204147,134 5.6%   
Gross profit Rs m86262,822 1.4%  
Depreciation Rs m1706,658 2.5%   
Interest Rs m1044,799 0.0%   
Profit before tax Rs m83018,567 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2145,108 4.2%   
Profit after tax Rs m61613,459 4.6%  
Gross profit margin %10.744.9 23.8%  
Effective tax rate %25.827.5 93.8%   
Net profit margin %7.69.6 79.5%  
BALANCE SHEET DATA
Current assets Rs m7,653251,882 3.0%   
Current liabilities Rs m3,923195,756 2.0%   
Net working cap to sales %46.340.1 115.4%  
Current ratio x2.01.3 151.6%  
Inventory Days Days611,969 3.1%  
Debtors Days Days394 920.2%  
Net fixed assets Rs m2,120816,105 0.3%   
Share capital Rs m50477 10.5%   
"Free" reserves Rs m5,044354,414 1.4%   
Net worth Rs m5,094354,891 1.4%   
Long term debt Rs m0437,784 0.0%   
Total assets Rs m9,7731,067,987 0.9%  
Interest coverage x88.41.4 6,250.5%   
Debt to equity ratio x01.2 0.0%  
Sales to assets ratio x0.80.1 629.1%   
Return on assets %6.45.5 117.3%  
Return on equity %12.13.8 318.8%  
Return on capital %16.58.0 206.2%  
Exports to sales %00-   
Imports to sales %31.70.2 14,702.6%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,552302 846.4%   
Fx inflow Rs m4421,125 39.3%   
Fx outflow Rs m2,552302 846.4%   
Net fx Rs m-2,110824 -256.1%   
CASH FLOW
From Operations Rs m1,00887,496 1.2%  
From Investments Rs m47-22,262 -0.2%  
From Financial Activity Rs m-95-69,880 0.1%  
Net Cashflow Rs m9617,000 13.7%  

Share Holding

Indian Promoters % 0.0 43.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 39.9 9.5%  
FIIs % 2.5 32.1 7.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 56.5 44.2%  
Shareholders   49,085 259,635 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Piramal Enterprises

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Piramal Enterprises Share Price Performance

Period ASTRAZENECA PHARMA Piramal Enterprises S&P BSE HEALTHCARE
1-Day -0.02% 0.04% 0.23%
1-Month 2.02% -3.16% 0.36%
1-Year 3.02% -36.60% -6.87%
3-Year CAGR 7.94% -5.74% 20.16%
5-Year CAGR 24.01% -11.34% 11.07%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Piramal Enterprises share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Piramal Enterprises the stake stands at 43.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Piramal Enterprises.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Piramal Enterprises paid Rs 33.0, and its dividend payout ratio stood at 58.5%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Piramal Enterprises.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.